Evidence map›Paper›PMID 16563222›Full record

ReviewJournal of cellular and molecular medicine

Morphological aspects of apoptosis in heart diseases.

Genzou Takemura, Hisayoshi Fujiwara

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of cellular and molecular medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
9.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 98 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Observational
  10. Article
  11. Early markers for myocardial ischemia and sudden cardiac death.International journal of legal medicine · 2016
    Article
  12. Article
  13. Review
  14. In situ ligation: a decade and a half of experience.Methods in molecular biology (Clifton, N.J.) · 2011
    Review
  15. Biomimetic matrices for myocardial stabilization and stem cell transplantation.Journal of biomedical materials research. Part A · 2010
    Article
  16. Article
  17. Apoptosis predominates in nonmyocytes in heart failure.American journal of physiology. Heart and circulatory physiology · 2009
    Article
  18. Myocardial survival signaling in response to stem cell transplantation.Journal of the American College of Surgeons · 2009
    Article
  19. The magnitude and temporal dependence of apoptosis early after myocardial ischemia with or without reperfusion.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2009
    Article
  20. Contractility in health and disease.Journal of cellular and molecular medicine · 2008
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Genzou TakemuraSecond Department of Internal Medicine, Gifu University School of Medicine, Yanagido, Gifu, Japan.
Hisayoshi Fujiwara
Gifu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been suggested that apoptosis may be responsible for a significant amount of cardiomyocyte death during acute myocardial infarction as well as for a progressive loss of surviving cells in failing hearts. Typical apoptosis can indeed be induced in cardiomyocytes at the experimental conditions. In actual heart diseases, in contrast, there is very little direct morphological evidence of apoptosis in cardiomyocytes occurring at any stage of myocardial infarction and heart failure, despite the availability of much indirect evidence that includes detection of DNA fragmentation and apoptosis-related factors. For that reason, the potential efficacy of therapeutic intervention to prevent apoptosis remains controversial. This review will survey available data from both animals and humans to critically assess the role of cardiomyocyte apoptosis during myocardial infarction and its relevance to myocardial remodeling and during progression to heart failure. Also considered will be nonmyocyte interstitial cells, which have received less attention than myocytes despite definitive evidence of their apoptosis in the infarcted heart and recent studies suggesting that blockade of apoptosis among these cells mitigates postinfarction cardiac remodeling and heart failure. We conclude from our survey that there are many hurdles to surmount before regulation of apoptosis can be clinically applied in the treatment of myocardial infarction and heart failure.

Indexed as

ApoptosisAnimalsAutophagyDisease ProgressionHeart DiseasesHumansMicroscopy, ElectronModels, BiologicalMyocardial InfarctionMyocardiumMyocytes, CardiacSignal TransductionTime Factors

Identifiers

PMID16563222
PMCPMC3933102
OpenAlexW1965158741

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.